Syra Health Corp
SYRA· OTC
SYRASyra Health Corp
Filed Oct 29, 2024 · 10-Q · 29 days after period end · 0001493152-24-042875
| Metric | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|
| Revenue | $2.25M | $1.58M | $1.51M |
| Net Income | -$417.54K | -$354.38K | -$354.54K |
| EPS Diluted | -$0.06 | -$0.08 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Oct 29, 2024 · 29 d after period end
